Osteoporosis Drugs
- All
- News
-
Osteoporosis: Can Yoga Asanas Reduce Osteoporosis Pain?
We discuss how yoga improves Osteoporosis symptoms. We also list 4 yoga positions that can help manage Osteoporosis.
-
Can You Treat Osteoporosis? Have A Look At Some Natural Ways To Build Healthy Bones
Thinning bones are a risk factor for experiencing a major bone break such as a hip. More common are compression fractures in the vertebrae of the spine.
-
Researchers Find New Potential Cure For Baldness: Top 5 Foods That Prevent Balding
A study published in the journal PLOS Biology has said that the osteoporosis drug helps by targeting a protein which inhibits the development of certain tissues, including hair follicles.
-
This Chinese Herb May Help Treat Osteoporosis: Study
Osteoporosis literally means porous bones. It is a disease wherein the density and quality of bones are reduced. As the bones become more fragile and porous, the risk of fracture increases. The loss of bone occurs progressively and yet silently
-
Lupin Launches Osteoporosis Drug in US
Drug firm Lupin has launched its generic norethindrone acetate and ethinyl estradiol tablets used for the prevention of postmenopausal osteoporosis in the US market.
-
Dr Reddy's Recalls 3,342 Vials of Osteoporosis Injection in US: Regulator
Drug firm Dr Reddy's Laboratories' US arm is recalling 3,342 vials of anti-osteoporosis injection, made by Hyderabad-based Gland Pharma, on account of lack of assurance of sterility.
-
Aurobindo Pharma Gets US Regulator's Nod for Osteoporosis Drug
Aurobindo Pharma has received final nod from the US Food and Drug Administration (FDA) to manufacture and market its generic Naproxen Sodium tablets used for the treatment of osteoporosis in postmenopausal women.
-
Aurobindo Pharma Gets Final USFDA Nod For Osteoporosis Drug
Drug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets, used for the treatment and prevention of osteoporosis in women, in the American market.
-
Sun Pharma Recalls 3.8 Lakh Cartons of Osteoporosis Drug in US: Report
Around 3.8 lakh cartons of an osteoporosis drug manufactured by domestic drug major Sun Pharmaceutical Industries are being recalled in the US and Puerto Rico due to presence of "unknown impurity".
-
Lupin Gets US Regulator Approval for Generic Femhrt Tablets
Drug major Lupin has received US health regulator's approval to market Fyavolv tablets, used to treat postmenopausal osteoporosis, in the American market.
-
Bone Drug Can Protect Stem Cells From Ageing: Study
A drug currently used to treat patients with osteoporosis can protect stem cells from ageing, a breakthrough study has found.
-
Aurobindo Pharma gets US Regulator's Nod for Osteoporosis Drug
Aurobindo Pharma on Tuesday said it has received final approval from the US Food and Drug Administration (FDA) to manufacture and market a generic version of risedronate sodium tablets, used in the treatment of osteoporosis, in the American market.
-
Indian-Origin Doctor Rita Luthra Indicted in Graft Case in US
An Indian-origin gynaecologist has been arrested in the US for allegedly accepting favours from a pharmaceutical company in return for prescribing its osteoporosis drugs, a media report said.
-
Aurobindo Gains on FDA Nod; Sun Pharma, Wockhardt Trade Mixed
Aurobindo Pharma shares jumped as much as 3.3 per cent to hit intraday high of Rs 779.70 after the company got approval from the US Food and Drug Administration (USFDA) to manufacture and market generic version of Eli Lilly's Evista tablets used for treatment of osteoporosis in post-menopausal women.
-
Aurobindo Pharma Gets USFDA Nod for Generic Osteoporosis Drug
The approval by the US FDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.
-
Osteoporosis: Can Yoga Asanas Reduce Osteoporosis Pain?
We discuss how yoga improves Osteoporosis symptoms. We also list 4 yoga positions that can help manage Osteoporosis.
-
Can You Treat Osteoporosis? Have A Look At Some Natural Ways To Build Healthy Bones
Thinning bones are a risk factor for experiencing a major bone break such as a hip. More common are compression fractures in the vertebrae of the spine.
-
Researchers Find New Potential Cure For Baldness: Top 5 Foods That Prevent Balding
A study published in the journal PLOS Biology has said that the osteoporosis drug helps by targeting a protein which inhibits the development of certain tissues, including hair follicles.
-
This Chinese Herb May Help Treat Osteoporosis: Study
Osteoporosis literally means porous bones. It is a disease wherein the density and quality of bones are reduced. As the bones become more fragile and porous, the risk of fracture increases. The loss of bone occurs progressively and yet silently
-
Lupin Launches Osteoporosis Drug in US
Drug firm Lupin has launched its generic norethindrone acetate and ethinyl estradiol tablets used for the prevention of postmenopausal osteoporosis in the US market.
-
Dr Reddy's Recalls 3,342 Vials of Osteoporosis Injection in US: Regulator
Drug firm Dr Reddy's Laboratories' US arm is recalling 3,342 vials of anti-osteoporosis injection, made by Hyderabad-based Gland Pharma, on account of lack of assurance of sterility.
-
Aurobindo Pharma Gets US Regulator's Nod for Osteoporosis Drug
Aurobindo Pharma has received final nod from the US Food and Drug Administration (FDA) to manufacture and market its generic Naproxen Sodium tablets used for the treatment of osteoporosis in postmenopausal women.
-
Aurobindo Pharma Gets Final USFDA Nod For Osteoporosis Drug
Drug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets, used for the treatment and prevention of osteoporosis in women, in the American market.
-
Sun Pharma Recalls 3.8 Lakh Cartons of Osteoporosis Drug in US: Report
Around 3.8 lakh cartons of an osteoporosis drug manufactured by domestic drug major Sun Pharmaceutical Industries are being recalled in the US and Puerto Rico due to presence of "unknown impurity".
-
Lupin Gets US Regulator Approval for Generic Femhrt Tablets
Drug major Lupin has received US health regulator's approval to market Fyavolv tablets, used to treat postmenopausal osteoporosis, in the American market.
-
Bone Drug Can Protect Stem Cells From Ageing: Study
A drug currently used to treat patients with osteoporosis can protect stem cells from ageing, a breakthrough study has found.
-
Aurobindo Pharma gets US Regulator's Nod for Osteoporosis Drug
Aurobindo Pharma on Tuesday said it has received final approval from the US Food and Drug Administration (FDA) to manufacture and market a generic version of risedronate sodium tablets, used in the treatment of osteoporosis, in the American market.
-
Indian-Origin Doctor Rita Luthra Indicted in Graft Case in US
An Indian-origin gynaecologist has been arrested in the US for allegedly accepting favours from a pharmaceutical company in return for prescribing its osteoporosis drugs, a media report said.
-
Aurobindo Gains on FDA Nod; Sun Pharma, Wockhardt Trade Mixed
Aurobindo Pharma shares jumped as much as 3.3 per cent to hit intraday high of Rs 779.70 after the company got approval from the US Food and Drug Administration (USFDA) to manufacture and market generic version of Eli Lilly's Evista tablets used for treatment of osteoporosis in post-menopausal women.
-
Aurobindo Pharma Gets USFDA Nod for Generic Osteoporosis Drug
The approval by the US FDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.
